Professor Paul Moss profile page

Paul Moss is Professor of Haematology within the Institute of Immunology and Immunotherapy at the University of Birmingham and Deputy Head of the College of Medical and Dental Sciences. He is an international figure in translational human immunology and an NIHR Senior Investigator. He was previously Chair of the Infection and Immunity Board at the Medical Research Council and also served as Chair of the Clinical and Translational Research Committee at Cancer Research UK. Professor Moss’s contributions to immunotherapy have been recognized through numerous publications in leading scientific journals and presentations at major conferences. His work continues to influence the development of new immunotherapeutic strategies and improve the treatment landscape for cancer patients. Through his research and leadership, Professor Paul Moss has made significant strides in advancing immunotherapy, shaping the future of cancer treatment and contributing to the ongoing evolution of personalized medicine. He is currently leading the immunity strand of the COVID-19 National Core Studies Programme, initiated by Sir Patrick Vallance in October 2020, that supports research to improve our understanding of immunity against COVID-19. As well as publishing in leading journals, including Nature, Blood and the European Journal of Immunology, Professor Moss's research has featured in the Financial Times, BBC News and The Economist.